Atorvastatin (10 mg) vs ezetimibe (10 mg) plus atorvastatin (10 mg) in hypercholesterolaemia and coronary heart disease (CHD)
Completed
- Conditions
- Hypercholesterolaemia and CHDNutritional, Metabolic, Endocrine
- Registration Number
- ISRCTN18808154
- Lead Sponsor
- Schering-Plough UK Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 0
Inclusion Criteria
Male or female subjects aged 18-75 with screening low-density lipoprotein cholesterol (LDL-C) between 3.3 and 4.9 mmol/
Exclusion Criteria
Not provided at time of registration
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method